10x Genomics Inc. (TXG)
NASDAQ · Healthcare
10x Genomics Inc. Cash on Hand 2017–2025
10x Genomics Inc. annual/quarterly cash on hand history from 2018 to 2024. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- 10x Genomics Inc. cash on hand for the quarter ending December 31, 2024 were 344.1M, a 4.24% decrease year-over-year.
- 10x Genomics Inc. cash on hand for 2024 were 344.1M, a 4.24% decrease from 2023.
- 10x Genomics Inc. cash on hand for 2023 were 359.3M, a 63.50% increase from 2022.
- 10x Genomics Inc. cash on hand for 2022 were 219.7M, a 62.59% decrease from 2021.
- 10x Genomics Inc. cash on hand for 2021 were 587.4M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| 10x Genomics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2024 | $344 |
| 2023 | $359 |
| 2022 | $220 |
| 2021 | $587 |
| 2020 | $664 |
| 2019 | $424 |
| 2018 | $65 |
| 10x Genomics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2024-12-31 | $344 |
| 2023-12-31 | $359 |
| 2022-12-31 | $220 |
| 2021-12-31 | $587 |
| 2020-12-31 | $664 |
| 2019-12-31 | $424 |
| 2018-12-31 | $65 |
10x Genomics Inc. Cash on Hand — FAQ
10x Genomics Inc. (TXG) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TXG's cash on hand history?
The chart and table above show 10x Genomics Inc.'s cash on hand by year and by quarter, including the growth rate.